C07F 9/5535
Condensed with carbocyclic rings or ring systems
Official title: {condensed with carbocyclic rings or ring systems}
C07F9/5535 (Condensed with carbocyclic rings or ring systems) appears on 24 US grants and 31 published applications in this corpus.
Search patents in C07F- Granted patents
- 24
- Published applications
- 31
- Assignees
- 22
- Inventors
- 73
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 3 |
| 2017 | 2 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 2 | 5 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzazepine compounds, preparation method therefor and pharmaceutical use thereof23 Jun 2026US 12,662,497 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Application of click chemistry for signal amplification in IHC and ISH assays6 Jan 2026US 12,517,132 B2Ventana Medical Systems, Inc.
- Application of click chemistry for signal amplification in IHC and ISH assays29 Jul 2025US 12,372,531 B2Ventana Medical Systems, Inc.
- Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors to reduce detrimental effects of perfusion deficiency of parenchymal organs24 Jun 2025US 12,337,001 B2
- Application of click chemistry for signal amplification in IHC and ISH assays2 Jan 2024US 11,860,167 B2Ventana Medical Systems, Inc.
- Dibenzodiazepines derivatives, pharmaceutical compositions and uses2 Jul 2026US 2026/0184731 A1Shenzhen Evergreen Therapeutics Co., Ltd.
- Compositions comprising modified phospholipids and uses thereof16 Oct 2025US 2025/0319025 A9Children's Medical Center Corporation
- Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors to reduce detrimental effects of perfusion deficiency of parenchymal organs9 Oct 2025US 2025/0312354 A1
- Haloalkyl sulfonanilide compound and herbicide containing the same18 Sep 2025US 2025/0289788 A1Sds Biotech K. K.
- Application of click chemistry for signal amplification in ihc and ish assays28 Aug 2025US 2025/0271441 A1Ventana Medical Systems, Inc.
Most cited
By later US patents
- Targeted drug delivery via phosphonate derivatives55US 5,177,064 AUniversity of Florida · 1993
- Targeted drug delivery via phosphonate derivatives53US 5,413,996 AUniversity of Florida · 1995
- Water-soluble analogs of carbamazepine28US 5,466,683 ATeva Pharmaceutical Industries Ltd. · 1995
- Targeted drug delivery via phosphonate derivatives18US 5,618,803 AUniversity of Florida · 1997
- Ansamycins having improved pharmacological and biological properties14US 7,465,718 B2Conforma Therapeutics Corporation · 2008